CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues:
Total revenues	$ 1,169,236	$ 762,658	$ 2,413,297	$ 1,996,995
Operating expenses:
Research and development	2,335,430	2,377,993	4,910,446	5,754,492
General and administrative	1,141,871	2,518,725	2,359,934	4,686,044
Total operating expenses	3,477,301	4,896,718	7,270,380	10,440,536
Loss from operations	(2,308,065)	(4,134,060)	(4,857,083)	(8,443,541)
Other income (expenses):
Interest income	115,388	35,080	271,584	119,734
Loss from continuing operations	(2,192,677)	(4,098,980)	(4,585,499)	(8,323,807)
Discontinued operations:
Loss from discontinued operations, net of tax		(2,179,657)		(2,922,406)
Gain on disposal of discontinued operations before income taxes		8,794,426		8,794,426
Income from discontinued operations		6,614,769		5,872,020
Net (loss) income	$ (2,192,677)	$ 2,515,789	$ (4,585,499)	$ (2,451,787)
Net (loss) earnings per share:
Loss from continuing operations, basic	$ (0.25)	$ (0.47)	$ (0.51)	$ (0.95)
Loss from continuing operations, diluted	(0.25)	(0.47)	(0.51)	(0.95)
Income from discontinued operations, basic		0.75		0.67
Income from discontinued operations, diluted		0.75		0.67
Net (loss) earnings per share, basic	(0.25)	0.29	(0.51)	(0.28)
Net (loss) earnings per share, diluted	$ (0.25)	$ 0.29	$ (0.51)	$ (0.28)
Weighted average number of common shares outstanding, basic	8,918,233	8,798,956	8,910,097	8,760,209
Weighted average number of common shares outstanding, diluted	8,918,233	8,798,956	8,910,097	8,760,209
Grant income
Revenues:
Total revenues	$ 1,169,236	$ 762,658	$ 2,413,297	$ 1,996,995